Previous issues

  • HOME
  • BROWSE ARTICLES
  • Previous issue
Volume 26(4); Oct 2020
Reviews
1526
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
Clin Mol Hepatol. 2020;26(4):383-400.   Published online July 17, 2020
View: 5302   Download: 409  Citations: 20
1525
Liver graft from donation after circulatory death donor: Real practice to improve graft viability
Koji Hashimoto
Clin Mol Hepatol. 2020;26(4):401-410.   Published online July 10, 2020
View: 2678   Download: 121  Citations: 2
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
Clin Mol Hepatol. 2020;26(4):411-429.   Published online August 28, 2020
View: 7287   Download: 944  Citations: 29
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clin Mol Hepatol. 2020;26(4):430-443.   Published online August 14, 2020
View: 4524   Download: 328  Citations: 13
1547
Managing liver cirrhotic complications: Overview of esophageal and gastric varices
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani
Clin Mol Hepatol. 2020;26(4):444-460.   Published online October 1, 2020
View: 4934   Download: 383  Citations: 18
1531
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2020;26(4):461-475.   Published online September 10, 2020
View: 3988   Download: 211  Citations: 15
Editorials
Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
Sooyeon Oh, Jooho Lee
Clin Mol Hepatol. 2020;26(4):476-479.   Published online October 1, 2020
View: 2142   Download: 110  Citations: 4
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
Naoshi Nishida
Clin Mol Hepatol. 2020;26(4):480-483.   Published online September 21, 2020
View: 2564   Download: 83  Citations: 4
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
Jaewhan Song
Clin Mol Hepatol. 2020;26(4):484-486.   Published online October 1, 2020
View: 3155   Download: 85  Citations: 3
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
Paul Kwo, Deepti Dronamraju
Clin Mol Hepatol. 2020;26(4):489-491.   Published online September 24, 2020
View: 1852   Download: 60
Original Articles
The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma
Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong
Clin Mol Hepatol. 2020;26(4):492-505.   Published online July 10, 2020
View: 9773   Download: 237  Citations: 13
Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee
Clin Mol Hepatol. 2020;26(4):506-515.   Published online July 10, 2020
View: 2761   Download: 137  Citations: 20
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol. 2020;26(4):516-528.   Published online September 11, 2020
View: 2840   Download: 144  Citations: 17
Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway
Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2020;26(4):529-539.   Published online August 24, 2020
View: 3682   Download: 160  Citations: 15
Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong
Clin Mol Hepatol. 2020;26(4):540-553.   Published online September 17, 2020
View: 2848   Download: 125  Citations: 7
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen
Clin Mol Hepatol. 2020;26(4):554-561.   Published online August 28, 2020
View: 2286   Download: 145  Citations: 2
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
Clin Mol Hepatol. 2020;26(4):562-576.   Published online October 1, 2020
View: 2954   Download: 158  Citations: 14
Letters to the Editor
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
Jeong Su Park, Soo Han Bae
Clin Mol Hepatol. 2020;26(4):577-578.   Published online September 17, 2020
View: 1600   Download: 50  Citation: 1
Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
Dimitrios Patoulias, Michael Doumas
Clin Mol Hepatol. 2020;26(4):582-583.   Published online September 25, 2020
View: 1590   Download: 57
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Dong Joon Kim, Won-Il Jeong, Hidekazu Tsukamoto, Bin Gao
Clin Mol Hepatol. 2020;26(4):584-585.   Published online October 1, 2020
View: 1515   Download: 61
Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
Seonghwan Hwang, Tianyi Ren, Bin Gao
Clin Mol Hepatol. 2020;26(4):586-594.   Published online September 17, 2020
View: 2743   Download: 141  Citations: 7
From intestinal dysbiosis to alcohol-associated liver disease
Beatriz Garcia Mendes, Bernd Schnabl
Clin Mol Hepatol. 2020;26(4):595-605.   Published online September 11, 2020
View: 3984   Download: 155  Citations: 9
Autophagy and liver cancer
Xiaojuan Chao, Hui Qian, Shaogui Wang, Sam Fulte, Wen-Xing Ding
Clin Mol Hepatol. 2020;26(4):606-617.   Published online October 1, 2020
View: 3394   Download: 138  Citations: 19
Programmed cell death in alcohol-associated liver disease
Tatsunori Miyata, Laura E. Nagy
Clin Mol Hepatol. 2020;26(4):618-625.   Published online September 21, 2020
View: 5682   Download: 177  Citations: 7
Inter-professional and inter-departmental alcoholism rehabilitation program
Masahiro Kikuchi, Naomi Matsutani, Ryota Ishihara, Masako Sugihara, Yuuki Mizuno, Chiyo Chiba, Takahiro Ohta, Eri Yamada, Sota Oguro, Yasuko Sato, Hiroki Bessho, Yoshinori Horie
Clin Mol Hepatol. 2020;26(4):626-632.   Published online October 1, 2020
View: 1786   Download: 50
The lymphatic system in alcohol-associated liver disease
Reiichiro Kondo, Yasuko Iwakiri
Clin Mol Hepatol. 2020;26(4):633-638.   Published online September 21, 2020
View: 3991   Download: 103
Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
Shiv Kumar Sarin, Shvetank Sharma
Clin Mol Hepatol. 2020;26(4):639-651.   Published online October 1, 2020
View: 4274   Download: 134  Citations: 2
Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies
Seung Ha Park, Dong Joon Kim
Clin Mol Hepatol. 2020;26(4):652-661.   Published online October 1, 2020
View: 1901   Download: 58  Citations: 3
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2020;26(4):662-669.   Published online September 25, 2020
View: 4179   Download: 130  Citations: 9
Liver-lung axes in alcohol-related liver disease
Gavin E. Arteel
Clin Mol Hepatol. 2020;26(4):670-676.   Published online October 1, 2020
View: 2181   Download: 64  Citations: 4
Roles of the complement system in alcohol-induced liver disease
Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He
Clin Mol Hepatol. 2020;26(4):677-685.   Published online October 1, 2020
View: 2761   Download: 91  Citations: 4
Emerging medical therapies for severe alcoholic hepatitis
David Tornai, Gyongyi Szabo
Clin Mol Hepatol. 2020;26(4):686-696.   Published online September 28, 2020
View: 2842   Download: 157  Citations: 3
Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell
Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong
Clin Mol Hepatol. 2020;26(4):697-704.   Published online October 1, 2020
View: 2314   Download: 95  Citation: 1
Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul
Clin Mol Hepatol. 2020;26(4):705-714.   Published online October 1, 2020
View: 1847   Download: 59  Citations: 2
Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol. 2020;26(4):715-727.   Published online September 22, 2020
View: 3512   Download: 183  Citations: 8
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
Clin Mol Hepatol. 2020;26(4):728-735.   Published online October 1, 2020
View: 2624   Download: 121  Citations: 10
Alcohol and hepatocarcinogenesis
Makiko Taniai
Clin Mol Hepatol. 2020;26(4):736-741.   Published online October 1, 2020
View: 2333   Download: 92  Citations: 5
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Yuchen Liu, Xiaohui Wang, Yingzi Yang
Clin Mol Hepatol. 2020;26(4):742-750.   Published online September 28, 2020
View: 3328   Download: 145  Citations: 19

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 182
TOTAL : 827650
Close layer